Ignite Creation Date:
2024-05-05 @ 11:48 AM
Last Modification Date:
2024-10-26 @ 9:14 AM
Study NCT ID:
NCT00139841
Status:
COMPLETED
Last Update Posted:
2014-05-09
First Post:
2005-08-18
Brief Title:
Safety and Efficacy of Treanda Bendamustine HCl in Patients With Indolent Non-Hodgkins Lymphoma NHL Who Are Refractory to Rituximab
Sponsor:
Cephalon
Organization:
Teva Branded Pharmaceutical Products RD Inc
Organization Data
Organization:
Teva Branded Pharmaceutical Products RD Inc
Class:
INDUSTRY
Study ID:
SDX-105-03
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Cephalon
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None